Navigation Links
Ginkgo Won't Slow Decline of Aging Brain

Popular herb doesn't keep cognitive powers intact, researchers say

TUESDAY, Dec. 29 (HealthDay News) -- Many older adults consume ginkgo biloba, hoping to keep their minds sharp, but a new study finds that the herbal product doesn't stave off cognitive decline.

"Measuring the effect of ginkgo in a big trial in older people, we didn't see any effect of the drug on slowing down or delaying normal age-related changes of cognition," said lead researcher Dr. Steven T. DeKosky, vice president and dean of the University of Virginia School of Medicine in Charlottesville.

"If you are older and thinking 'I'll try ginkgo to preserve brain health,' we have no evidence that it is useful," he said. "I won't take it anymore."

The report, published in the Dec. 23-30 issue of the Journal of the American Medical Association, supports the findings of earlier, smaller studies.

To test ginkgo's effect on cognitive decline, DeKosky's group looked at results from the ginkgo Evaluation of Memory study, which included 3,069 community-dwelling adults 72 to 96 years of age. The participants, who were generally healthy when the study began, either took 120 milligrams of ginkgo or placebo twice a day and were routinely tested for cognitive abilities.

Over more than six years of follow-up, the researchers found no evidence that ginkgo delayed or prevented normal declines in memory, language, attention, visuospatial abilities or executive functions, such as anticipating outcomes and adapting to changing situations and thinking abstractly.

These results remained the same regardless of sex, age, race or education, the researchers noted.

However, ginkgo was safe and no serious side effects were noted, DeKosky added. "The good news is it appeared that it was fairly safe; the bad news was it didn't seem to do anything at least as far as trying to slow down the cognitive changes of aging."

Earlier results from the same study found that ginkgo did not prevent or slow the development of Alzheimer's or other dementias, DeKosky said.

The American Botanical council took issue with the findings, however.

"There are many significant limitations of this study," Mark Blumenthal, council founder and executive director said in a statement.

"First, the data being published this week are drawn from a previous clinical trial which was not designed to determine the decline in cognition. Second, about 40 percent of the subjects dropped out over the six-year duration of the trial; the statistics reported in the study include the dropouts for which no final data are available," Blumenthal said. "Further, the subjects in the study were not monitored for certain cognitive parameters until several years after the trial began, creating difficulty in determining accurately whether they experienced a decline in cognition or not. Also, the age of the subjects is quite advanced, at an average of 79 years at the beginning of the trial. This age group is not typical of the age of both healthy people and those with mild cognitive impairment who use ginkgo for improving mental performance."

Another group, the Council for Responsible Nutrition (CRN), which represents the dietary supplement industry, also had reservations about the study.

In a statement, Douglas MacKay, CRN's vice president of scientific and regulatory affairs, said that "there is a large body of previously published evidence, as well as ongoing trials, which suggest that ginkgo biloba is effective for helping to improve cognitive impairment in older adults." He added that, "as a former practicing naturopathic doctor, I have had the benefit of working with patients and have seen firsthand how ginkgo biloba can be effective in improving cognitive function."

Ginkgo biloba is believed to have antioxidant and anti-inflammatory properties that protect cell membranes and help govern the workings of the brain's chemical messengers, or neurotransmitters.

Dr. Lon S. Schneider, director of the state of California's Alzheimer's Disease Research and Clinical Center at the University of Southern California, Los Angeles, said that these findings were "straightforward and expected."

No measurable effect from ginkgo is seen on cognition, Schneider said. "Regardless of whether people say 'I take it and I feel better,' you just don't see an effect," he said.

Still, Schneider won't object if someone wants to try it. "It is not in my position to deflate hope," he said. "If someone really feels they need to take this and they need to try it, well go ahead and do it. But their expectations should be realistic, and if they don't experience anything, then they probably should stop."

More information

For more information on ginkgo biloba, go to the U.S. National Center for Complementary and Alternative Medicine.

SOURCES: Steven T. DeKosky, M.D., vice president and dean, University of Virginia School of Medicine, Charlottesville; Lon S. Schneider, M.D., director, State of California Alzheimer's Disease Research and Clinical Center at the University of Southern California, Los Angeles; statements, Dec. 28, 2009, Council for Responsible Nutrition, American Botanical Council; Dec. 23-30, 2009, Journal of the American Medical Association

Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Ginkgo Wont Prevent Heart Attack, Stroke in Elderly
2. Tianyin Pharmaceutical Co. Inc.s Ginkgo Mihuan Oral Solution Completes 2009 Tenders
3. Ginkgo Biloba for Prevention of Dementia
4. Ginkgo No Shield Against Alzheimers
5. Ginkgo Biloba Might Not Preserve Memory in Octogenarians
6. Strict Blood Sugar Lowering Wont Ease Diabetes Heart Risk
7. Elderly Report Rising Rates of Disability After 20-Year Decline
8. Disability may be on the rise again after 20-year decline
9. New Survey Shows Slow Decline in Youth Smoking, Troubling Increase in Smokeless Tobacco Use - Congress, States Must Step Up Tobacco Prevention Efforts
10. Breast Cancer Decline Only Partly Due to HRT
11. U.S. Swine Flu Cases Chart Sharp Decline
Post Your Comments:
(Date:10/10/2015)... ... ... have to walk with crutches for the rest of my life," said an inventor from ... that would give me more independence and freedom would be amazing. This inspired me to ... developed the STRAP IN to enable an individual to walk with crutches without having to ...
(Date:10/10/2015)... ... , ... The Bank of America 500 NASCAR Sprint Cup Series race is ... defending race winner, Kevin Harvick, will battle it out for the checkered flag with ... the stars of the NASCAR Sprint Cup Series. As part of the opening ...
(Date:10/10/2015)... ... October 10, 2015 , ... Attending medical school and ... men, women and children. Depending on the school, the exact details of the ... field. , Students in a medical school must complete undergraduate classwork and requirements ...
(Date:10/10/2015)... PA (PRWEB) , ... October 10, 2015 , ... ... Wigrizer, Brecher & Miller is pleased to be recognized by The National Law ... This list acknowledges the 50 law firms across the United States who obtained ...
(Date:10/9/2015)... ... October 09, 2015 , ... Doctors on Liens ... in Fresno , to provide highly needed medical care to personal injury victims. ... medical providers to diagnose, document and treat the variety of conditions ailing them. ...
Breaking Medicine News(10 mins):
... Calif., Sept. 8 (Nasdaq: WHRTD ) - World ... the Company received a NASDAQ Staff Deficiency Letter indicating that the ... This rule requires the Company to maintain a minimum of 500,000 ... Subsequently on September 4, 2009, the Company received a letter from ...
... , WESTON, Fla., Sept. 8 Kidz-Med ... today announced the receipt of a follow-up purchase order of equal ... and closed a large purchase of Kidz-Med,s ... Company,s history. , , Dr. Christopher ...
... , Expanding facility will provide training ... the Highbridge area of the Bronx , , ... officially open the newest addition to the non-profit agency on September ... cutting ceremony at the facility. Located at 1438 Ogden Ave., ...
... NEW YORK, NY, Sept. 8 /PRNewswire-FirstCall/ - (OTCBB: ... company that identifies, acquires, and develops novel drug ... today announced it has appointed Dr. Anders Boegh ... Dr. Boegh Jensen will contribute his considerable expertise ...
... results for recipients in study , TUESDAY, Sept. 8 ... organ donors may help preserve the quality of their ... Most transplanted kidneys come from donors whose hearts are ... chain of events that can damage organs and increase ...
... Ohio Hairstylists may have a unique opportunity to ... according to a small, exploratory study. More than ... older clients often or always shared their problems during ... to notice when their older clients are starting to ...
Cached Medicine News:
(Date:10/9/2015)... 2015 Eli Lilly and Company (NYSE: LLY ... approximately 50 new jobs to its research and development presence ... York, New York . --> ... will include a translational immuno-oncology hub and a Lilly "portal," ... access to cutting-edge drug discovery capabilities, including chemistry and lead ...
(Date:10/9/2015)... 2015 Ansun BioPharma announced a presentation at ... ) regarding the compassionate use of DAS181 under an ... who was co-infected with influenza and parainfluenza (Abstract # ... O 2 requirement was reduced and the patient,s ... go off the respirator on day 5. Between day ...
(Date:10/9/2015)... El ,JCA-Mauvernay Award 2015, se ha otorgado a los ... Junko Takita    --> El ,JCA-Mauvernay Award 2015, ... y Junko Takita    --> ... a los doctores Yutaka Kondo y ... global con sede enSuiza, presentará el ,JCA-Mauvernay Award, el 10 de octubre a ...
Breaking Medicine Technology:
... AstraZeneca (NYSE:,AZN) today announced that it submitted ... Food and Drug Administration (FDA) for approval of ... for the treatment of patients with Chronic Obstructive,Pulmonary ... long-term,maintenance treatment of asthma in patients 12 years ...
... Inc. ("QI"),announces the commencement of a Phase I/II ... a novel anti-cancer vaccine/immunotherapy that will,be used on ... accepted,into the study have previously failed to respond ... QI has commissioned,the study to be done by ...
Cached Medicine Technology:
... ideal where space is restricted. Due to ... and flexible in every situation. For many ... be positioned optimally on the JUPITER during ... the operating theatre, the high level of ...
... schaerer axis 800 operating ... designed for those disciplines ... access. The stability, the ... the offset positioned telescoping ...
... words "mobile operating table" literally! The Alphastar 1132 ... of a general purpose operating table - is ... operations, a cable connected hand control, an IR-hand ... there is a control panel at the top ...
... introduce the Cmax operating table that combines ... surgical table with the radiolucence and precise ... the most advanced, versatile surgical table on ... to support advancements in surgical procedures and ...
Medicine Products: